Last modified by Sarantis Dimitriadis on 2023/12/08 13:20
From version 5.9
edited by Sarantis Dimitriadis
on 2022/06/07 08:54
Change comment: There is no comment for this version
To version 11.1
edited by Sarantis Dimitriadis
on 2023/05/30 16:53
Change comment: There is no comment for this version

Summary

Details

Page properties
Content
... ... @@ -7,6 +7,8 @@
7 7  (% class="western" lang="en-GB" style="text-align:justify" %)
8 8  (% lang="en-US" %)End users can be classified to non-professional and professional groups. Typical non-professional and professional end-user groups in health and wellbeing includes the following:
9 9  
10 +:
11 +
10 10  * (((
11 11  (% lang="en-US" %)**Non-professional end users:**
12 12  
... ... @@ -15,6 +15,8 @@
15 15  * (% lang="en-US" %)**Public health and social service clients: **Those who use public services.
16 16  )))
17 17  
20 +:
21 +
18 18  * (((
19 19  (% lang="en-US" %)**Professional end users**
20 20  
... ... @@ -25,9 +25,13 @@
25 25  * (% lang="en-US" %)**Policy and decisions makers:** Those responsible for making policies and decisions at local, regional, national or international level.
26 26  )))
27 27  
32 +:
33 +
28 28  (% class="western" lang="en-GB" %)
29 29  (% lang="en-US" %)**Business-to-Business Customer (B2B):** B2B-customer is an organization that purchases living lab services from a living lab. B2B-customers can be classified to private, public, education/ research, civil society organizations and networks/cluster groups as follows:
30 30  
37 +:
38 +
31 31  * (((
32 32  (% lang="en-US" %)**Private sector organizations: **(business developers and researchers)
33 33  
... ... @@ -42,6 +42,8 @@
42 42  * (% lang="en-US" %)Pharmaceutical companies
43 43  )))
44 44  
53 +:
54 +
45 45  * (((
46 46  (% lang="en-GB" %)
47 47  (% lang="en-US" %)**Public sector organizations:**
... ... @@ -57,6 +57,8 @@
57 57  * (% lang="en-US" %)**Public funder:** Government or other European, national, regional or local public institutions who is providing public funding for a specific living lab living lab research project via call for application process.
58 58  )))
59 59  
70 +:
71 +
60 60  * (((
61 61  (% lang="en-GB" %)
62 62  (% lang="en-US" %)**Education and research organizations:**
... ... @@ -70,6 +70,8 @@
70 70  * (% lang="en-US" %)**Private research organizations** such as technology and innovation centers
71 71  )))
72 72  
85 +:
86 +
73 73  * (((
74 74  (% lang="en-GB" %)
75 75  (% lang="en-US" %)**Civil society organizations:**
... ... @@ -77,6 +77,8 @@
77 77  * (% lang="en-US" %)Non-governmental organizations (NGO) and nonprofit entities operating at international, national, regional or local level.
78 78  )))
79 79  
94 +:
95 +
80 80  * (((
81 81  (% lang="en-GB" %)
82 82  (% lang="en-US" %)**Networks and clusters:**
... ... @@ -88,256 +88,108 @@
88 88  :
89 89  
90 90  (% class="western" lang="en-GB" %)
91 -(% lang="en-US" %)Typical approaches to define (%%)non-professional end users (a.k.a. study participants) in health and wellbeing living lab projects are presented in Table .
107 +(% lang="en-US" %)Typical approaches to define (%%)//**non-professional **//end users (a.k.a. study participants) in health and wellbeing living lab projects are presented in the following table .
92 92  
93 -(% style="margin-left:auto; margin-right:auto" %)
94 -|(% colspan="4" style="border-color:#000000 currentcolor; border-style:solid none; border-width:1px medium; height:11px; text-align:center; vertical-align:middle; width:634px" %)(((
95 -(% class="western" lang="en-GB" style="text-align:center" %)
96 -(% lang="en-US" %)**Age or age group**
97 -)))
98 -|(% style="border-color:currentcolor; border-style:none; border-width:medium; height:30px; text-align:justify; vertical-align:middle; width:153px" %)(((
109 +(% style="margin-left:auto; margin-right:auto; width:1694px" %)
110 +|(% colspan="4" style="border-color:#000000 currentcolor; border-style:solid none; border-width:1px medium; height:11px; text-align:center; vertical-align:middle; width:634px" %)**Age groups**
111 +|(% style="border-color:currentcolor; border-style:none; border-width:medium; height:40px; text-align:justify; vertical-align:middle; width:152px" %)(((
99 99  (% lang="en-US" %)Specific age range
100 -)))|(% style="border-color:currentcolor; border-style:none; border-width:medium; height:30px; text-align:justify; vertical-align:middle; width:153px" %)(((
113 +)))|(% style="border-color:currentcolor; border-style:none; border-width:medium; height:40px; text-align:justify; vertical-align:middle; width:152px" %)(((
101 101  
102 -)))|(% style="border-color:currentcolor; border-style:none; border-width:medium; height:30px; text-align:justify; vertical-align:middle; width:153px" %)(((
115 +)))|(% style="border-color:currentcolor; border-style:none; border-width:medium; height:40px; text-align:justify; vertical-align:middle; width:152px" %)(((
103 103  (% class="western" %)
104 104  
105 -)))|(% style="border-color:currentcolor; border-style:none; border-width:medium; height:30px; text-align:justify; vertical-align:middle; width:152px" %)(((
118 +)))|(% style="border-color:currentcolor; border-style:none; border-width:medium; height:40px; text-align:justify; vertical-align:middle; width:152px" %)(((
106 106  (% class="western" %)
107 107  
108 108  )))
109 -|(% style="border-color:currentcolor; border-style:none; border-width:medium; height:30px; text-align:justify; vertical-align:middle; width:153px" %)(((
122 +|(% style="border-color:currentcolor; border-style:none; border-width:medium; height:50px; text-align:justify; vertical-align:middle; width:152px" %)Adolescents|(% style="border-color:currentcolor; border-style:none; border-width:medium; height:50px; text-align:justify; vertical-align:middle; width:152px" %)Adults|(% style="border-color:currentcolor; border-style:none; border-width:medium; height:50px; text-align:justify; vertical-align:middle; width:152px" %)Older Adults|(% style="border-color:currentcolor; border-style:none; border-width:medium; height:50px; text-align:justify; vertical-align:middle; width:152px" %)General Population
123 +|(% colspan="4" style="border-color:#000000 currentcolor; border-style:solid none; border-width:1px medium; height:30px; text-align:center; vertical-align:middle; width:634px" %)**Adolescents Health status (disease, disorder or disability)**
124 +|(% style="border-color:currentcolor; border-style:none; border-width:medium; height:50px; text-align:justify; vertical-align:middle; width:152px" %)(((
110 110  (% class="western" lang="en-GB" %)
111 -(% lang="en-US" %)Elderly
112 -)))|(% style="border-color:currentcolor; border-style:none; border-width:medium; text-align:justify; vertical-align:middle; width:153px" %)(((
126 +(% lang="en-US" %)Healthy
127 +)))|(% style="border-color:currentcolor; border-style:none; border-width:medium; height:50px; text-align:justify; vertical-align:middle; width:153px" %)(((
113 113  (% class="western" lang="en-GB" %)
114 -(% lang="en-US" %)Adults
115 -)))|(% style="border-color:currentcolor; border-style:none; border-width:medium; text-align:justify; vertical-align:middle; width:153px" %)(((
116 -(% class="western" lang="en-GB" %)
117 -(% lang="en-US" %)Youth
118 -)))|(% style="border-color:currentcolor; border-style:none; border-width:medium; text-align:justify; vertical-align:middle; width:152px" %)(((
119 -(% class="western" lang="en-GB" %)
120 -(% lang="en-US" %)Children
121 -)))
122 -|(% colspan="4" style="border-color:currentcolor; border-style:none; border-width:medium; height:30px; vertical-align:top; width:634px" %)(((
123 -(% class="western" %)
124 124  
125 -)))
126 -|(% colspan="4" style="border-color:#000000 currentcolor; border-style:solid none; border-width:1px medium; height:30px; text-align:center; vertical-align:middle; width:634px" %)(((
127 -(% class="western" lang="en-GB" style="text-align:center" %)
128 -(% lang="en-US" %)**Health status**
129 -)))
130 -|(% style="border-color:currentcolor; border-style:none; border-width:medium; height:30px; text-align:justify; vertical-align:middle; width:153px" %)(((
130 +)))|(% style="border-color:currentcolor; border-style:none; border-width:medium; height:50px; text-align:justify; vertical-align:middle; width:153px" %)(((
131 131  (% class="western" lang="en-GB" %)
132 -(% lang="en-US" %)Healthy
133 -)))|(% style="border-color:currentcolor; border-style:none; border-width:medium; text-align:justify; vertical-align:middle; width:153px" %)(((
134 -(% class="western" lang="en-GB" %)
135 -(% lang="en-US" %)Patient
136 -)))|(% style="border-color:currentcolor; border-style:none; border-width:medium; text-align:justify; vertical-align:middle; width:153px" %)(((
137 -(% class="western" lang="en-GB" %)
138 -(% lang="en-US" %)Rehabilitant
139 -)))|(% style="border-color:currentcolor; border-style:none; border-width:medium; text-align:justify; vertical-align:middle; width:152px" %)(((
140 -(% class="western" lang="en-GB" %)
141 -(% lang="en-US" %)Recovered/Survivor
142 -)))
143 -|(% colspan="4" style="border-color:currentcolor; border-style:none; border-width:medium; height:30px; vertical-align:top; width:634px" %)(((
144 -(% class="western" %)
145 145  
146 -)))
147 -|(% colspan="4" style="border-color:#000000 currentcolor; border-style:solid none; border-width:1px medium; height:30px; text-align:center; vertical-align:middle; width:634px" %)(((
148 -(% class="western" lang="en-GB" style="text-align:center" %)
149 -(% lang="en-US" %)**A specific disease, disorder or disability**
150 -)))
151 -|(% style="border-color:currentcolor; border-style:none; border-width:medium; height:30px; text-align:left; vertical-align:middle; width:153px" %)(((
133 +)))|(% style="border-color:currentcolor; border-style:none; border-width:medium; height:50px; text-align:justify; vertical-align:middle; width:152px" %)(((
152 152  (% class="western" lang="en-GB" %)
153 -(% lang="en-US" %)ADHD
154 -)))|(% style="border-color:currentcolor; border-style:none; border-width:medium; text-align:left; vertical-align:middle; width:153px" %)(((
155 -(% class="western" lang="en-GB" %)
156 -(% lang="en-US" %)Dementia
157 -)))|(% style="border-color:currentcolor; border-style:none; border-width:medium; text-align:left; vertical-align:middle; width:153px" %)(((
158 -(% class="western" lang="en-GB" %)
159 -(% lang="en-US" %)Parkinsons’ disease
160 -)))|(% style="border-color:currentcolor; border-style:none; border-width:medium; text-align:left; vertical-align:middle; width:152px" %)(((
161 -(% class="western" lang="en-GB" %)
162 -(% lang="en-US" %)Loneliness and Social Isolation
163 -)))
164 -|(% style="border-color:currentcolor; border-style:none; border-width:medium; height:30px; text-align:left; vertical-align:middle; width:153px" %)(((
165 -(% class="western" lang="en-GB" %)
166 -(% lang="en-US" %)Autism
167 -)))|(% style="border-color:currentcolor; border-style:none; border-width:medium; text-align:left; vertical-align:middle; width:153px" %)(((
168 -(% class="western" lang="en-GB" %)
169 -(% lang="en-US" %)Down syndrome
170 -)))|(% style="border-color:currentcolor; border-style:none; border-width:medium; text-align:left; vertical-align:middle; width:153px" %)(((
171 -(% class="western" lang="en-GB" %)
172 -(% lang="en-US" %)Physical disability
173 -)))|(% style="border-color:currentcolor; border-style:none; border-width:medium; text-align:left; vertical-align:middle; width:152px" %)(((
174 -(% class="western" lang="en-GB" %)
175 -(% lang="en-US" %)Mental health
176 -)))
177 -|(% style="border-color:currentcolor; border-style:none; border-width:medium; height:30px; text-align:left; vertical-align:middle; width:153px" %)(((
178 -(% class="western" lang="en-GB" %)
179 -(% lang="en-US" %)Cardiovascular disease
180 -)))|(% style="border-color:currentcolor; border-style:none; border-width:medium; text-align:left; vertical-align:middle; width:153px" %)(((
181 -(% class="western" lang="en-GB" %)
182 -(% lang="en-US" %)Idiopathic pulmonary fibrosis (IPF)
183 -)))|(% style="border-color:currentcolor; border-style:none; border-width:medium; text-align:left; vertical-align:middle; width:153px" %)(((
184 -(% class="western" lang="en-GB" %)
185 -(% lang="en-US" %)Sleep apnea/apnea
186 -)))|(% style="border-color:currentcolor; border-style:none; border-width:medium; text-align:left; vertical-align:middle; width:152px" %)(((
187 -(% class="western" lang="en-GB" %)
188 -(% lang="en-US" %)Mild cognitive impairment
189 -)))
190 -|(% style="border-color:currentcolor; border-style:none; border-width:medium; height:30px; text-align:left; vertical-align:middle; width:153px" %)(((
191 -(% class="western" lang="en-GB" %)
192 -(% lang="en-US" %)Chronic Obstructive Pulmonary Disease (COPD)
193 -)))|(% style="border-color:currentcolor; border-style:none; border-width:medium; text-align:left; vertical-align:middle; width:153px" %)(((
194 -(% class="western" lang="en-GB" %)
195 -(% lang="en-US" %)Language disability
196 -)))|(% style="border-color:currentcolor; border-style:none; border-width:medium; text-align:left; vertical-align:middle; width:153px" %)(((
197 -(% class="western" lang="en-GB" %)
198 -(% lang="en-US" %)Substance abuse (drugs, alcohol)
199 -)))|(% style="border-color:currentcolor; border-style:none; border-width:medium; text-align:left; vertical-align:middle; width:152px" %)(((
200 -(% class="western" lang="en-GB" %)
201 -(% lang="en-US" %)Multiple sclerosis
202 -)))
203 -|(% style="border-color:currentcolor; border-style:none; border-width:medium; height:30px; text-align:left; vertical-align:middle; width:153px" %)(((
204 -(% class="western" lang="en-GB" %)
205 -(% lang="en-US" %)Cognitive disorder (mild, major)
206 -)))|(% style="border-color:currentcolor; border-style:none; border-width:medium; text-align:left; vertical-align:middle; width:153px" %)(((
207 -(% class="western" lang="en-GB" %)
208 -(% lang="en-US" %)Intellectual disability/ Learning difficulty/ Mental retardation
209 -)))|(% style="border-color:currentcolor; border-style:none; border-width:medium; text-align:left; vertical-align:middle; width:153px" %)(((
210 -(% class="western" lang="en-GB" %)
211 -(% lang="en-US" %)Trauma patient
212 -
213 -(% class="western" lang="en-GB" %)
214 -(% lang="en-US" %)(e.g., a spinal cord injury)
215 -)))|(% style="border-color:currentcolor; border-style:none; border-width:medium; text-align:left; vertical-align:middle; width:152px" %)(((
216 -(% class="western" lang="en-GB" %)
217 -(% lang="en-US" %)Neurodegenerative diseases
218 -)))
219 -|(% colspan="4" style="border-color:currentcolor; border-style:none; border-width:medium; height:30px; vertical-align:top; width:634px" %)(((
220 -(% class="western" %)
221 221  
222 222  )))
223 -|(% colspan="4" style="border-color:#000000 currentcolor; border-style:solid none; border-width:1px medium; height:30px; text-align:center; vertical-align:middle; width:634px" %)(((
224 -(% class="western" lang="en-GB" style="text-align:center" %)
225 -(% lang="en-US" %)**Clients of a specific service**
226 -)))
227 -|(% style="border-color:currentcolor; border-style:none; border-width:medium; height:30px; text-align:left; vertical-align:middle; width:153px" %)(((
137 +|(% colspan="4" style="border-color:#000000 currentcolor; border-style:solid none; border-width:1px medium; height:30px; text-align:center; vertical-align:middle; width:634px" %)**Adults Health status (disease, disorder or disability)**
138 +|(% style="border-color:currentcolor; border-style:none; border-width:medium; height:30px; text-align:justify; vertical-align:middle; width:152px" %)Healthy|(% style="border-color:currentcolor; border-style:none; border-width:medium; height:30px; text-align:justify; vertical-align:middle; width:152px" %)Schizophrenia|(% style="border-color:currentcolor; border-style:none; border-width:medium; height:30px; text-align:justify; vertical-align:middle; width:152px" %)Multiple-Sclerosis|(% style="border-color:currentcolor; border-style:none; border-width:medium; height:30px; text-align:justify; vertical-align:middle; width:152px" %)Parkinson Disease
139 +|(% style="border-color:currentcolor; border-style:none; border-width:medium; height:30px; text-align:left; vertical-align:middle; width:152px" %)Post-Stroke Patients with Moving or Linguistic Disability|(% style="border-color:currentcolor; border-style:none; border-width:medium; height:30px; text-align:justify; vertical-align:middle; width:152px" %)Mild Cognitive Impairment|(% style="border-color:currentcolor; border-style:none; border-width:medium; height:30px; text-align:justify; vertical-align:middle; width:152px" %)Sleep Disorders: e.g., Apnea, Hypopnea|(% style="border-color:currentcolor; border-style:none; border-width:medium; height:30px; text-align:justify; vertical-align:middle; width:152px" %)With Disability
140 +|(% style="border-color:currentcolor; border-style:none; border-width:medium; height:50px; text-align:justify; vertical-align:middle; width:152px" %)Healthy with Possible Chronic Conditions|(% style="border-style:none; border-width:medium; height:50px; text-align:justify; vertical-align:middle; width:152px" %) |(% style="border-style:none; border-width:medium; height:50px; text-align:justify; vertical-align:middle; width:152px" %) |(% style="border-style:none; border-width:medium; height:50px; text-align:justify; vertical-align:middle; width:152px" %)
141 +|(% colspan="4" style="border-color:#000000 currentcolor; border-style:solid none; border-width:1px medium; height:30px; text-align:center; vertical-align:middle; width:634px" %)**Older Adults Health status (disease, disorder or disability)**
142 +|(% style="border-color:currentcolor; border-style:none; border-width:medium; height:30px; text-align:justify; vertical-align:middle; width:152px" %)Healthy|(% style="border-color:currentcolor; height:30px; text-align:justify; vertical-align:middle; width:152px" %)Parkinson Disease|(% style="border-color:currentcolor; height:30px; text-align:justify; vertical-align:middle; width:152px" %)Mild Cognitive Impairment|(% style="border-color:currentcolor; height:30px; text-align:justify; vertical-align:middle; width:152px" %)With Disability
143 +|(% style="border-color:currentcolor; border-style:none; border-width:medium; height:50px; text-align:justify; vertical-align:middle; width:152px" %)Healthy with Possible Chronic Conditions|(% style="border-style:none; border-width:medium; height:50px; text-align:justify; vertical-align:middle; width:152px" %)(((
228 228  (% class="western" lang="en-GB" %)
229 -(% lang="en-US" %)Child welfare
230 -)))|(% style="border-color:currentcolor; border-style:none; border-width:medium; text-align:left; vertical-align:middle; width:153px" %)(((
231 -(% class="western" lang="en-GB" %)
232 -(% lang="en-US" %)Nursing home
233 -)))|(% style="border-color:currentcolor; border-style:none; border-width:medium; text-align:left; vertical-align:middle; width:153px" %)(((
234 -(% class="western" lang="en-GB" %)
235 -(% lang="en-US" %)Employment service
236 -)))|(% style="border-color:currentcolor; border-style:none; border-width:medium; text-align:left; vertical-align:middle; width:152px" %)(((
237 -(% class="western" %)
238 238  
239 -)))
240 -|(% style="border-color:currentcolor; border-style:none; border-width:medium; height:30px; text-align:left; vertical-align:middle; width:153px" %)(((
146 +)))|(% style="border-style:none; border-width:medium; height:50px; text-align:justify; vertical-align:middle; width:152px" %)(((
241 241  (% class="western" lang="en-GB" %)
242 -(% lang="en-US" %)Early childhood education
243 -)))|(% style="border-color:currentcolor; border-style:none; border-width:medium; text-align:left; vertical-align:middle; width:153px" %)(((
244 -(% class="western" lang="en-GB" %)
245 -(% lang="en-US" %)Home care
246 -)))|(% style="border-color:currentcolor; border-style:none; border-width:medium; text-align:left; vertical-align:middle; width:153px" %)(((
247 -(% class="western" lang="en-GB" %)
248 248  
249 -)))|(% style="border-color:currentcolor; border-style:none; border-width:medium; text-align:left; vertical-align:middle; width:152px" %)(((
149 +)))|(% style="border-style:none; border-width:medium; height:50px; text-align:justify; vertical-align:middle; width:152px" %)(((
250 250  (% class="western" lang="en-GB" %)
251 251  
252 252  )))
253 -|(% colspan="4" style="border-color:currentcolor; border-style:none; border-width:medium; height:30px; vertical-align:top; width:634px" %)(((
254 -(% class="western" %)
255 -
256 -)))
257 -|(% colspan="4" style="border-color:#000000 currentcolor; border-style:solid none; border-width:1px medium; height:30px; text-align:center; vertical-align:middle; width:634px" %)(((
258 -(% class="western" lang="en-GB" style="text-align:center" %)
259 -(% lang="en-US" %)**Vulnerable groups**
260 -)))
261 -|(% style="border-color:currentcolor; border-style:none; border-width:medium; height:30px; text-align:left; vertical-align:middle; width:153px" %)(((
153 +|(% colspan="4" style="border-color:#000000 currentcolor; border-style:solid none; border-width:1px medium; height:30px; text-align:center; vertical-align:middle; width:634px" %)**General Population Health status (disease, disorder or disability)**
154 +|(% style="border-color:currentcolor; border-style:none; border-width:medium; height:30px; text-align:justify; vertical-align:middle; width:152px" %)Healthy|(% style="text-align:justify; vertical-align:middle" %)Ipf Patients|(% style="border-color:currentcolor; border-style:none; border-width:medium; text-align:justify; vertical-align:middle; width:152px" %)Prostate Cancer|(% style="border-color:currentcolor; border-style:none; border-width:medium; text-align:justify; vertical-align:middle; width:152px" %)(((
262 262  (% class="western" lang="en-GB" %)
263 -(% lang="en-US" %)Minors/Children
264 -)))|(% style="border-color:currentcolor; border-style:none; border-width:medium; text-align:left; vertical-align:middle; width:153px" %)(((
265 -(% class="western" lang="en-GB" %)
266 -(% lang="en-US" %)Single parents with minor children
267 -)))|(% style="border-color:currentcolor; border-style:none; border-width:medium; text-align:left; vertical-align:middle; width:153px" %)(((
268 -(% class="western" lang="en-GB" %)
269 -(% lang="en-US" %)Persons subjected to psychological, physical or sexual violence
270 -)))|(% style="border-color:currentcolor; border-style:none; border-width:medium; text-align:left; vertical-align:middle; width:152px" %)(((
271 -(% class="western" lang="en-GB" %)
272 -(% lang="en-US" %)Substance users
273 -
274 -(% class="western" lang="en-GB" %)
275 -(% lang="en-US" %)(drugs, alcohol)
156 +Down Syndrome
276 276  )))
277 -|(% style="border-color:currentcolor; border-style:none; border-width:medium; height:30px; text-align:left; vertical-align:middle; width:153px" %)(((
158 +|(% style="border-color:currentcolor; border-style:none; border-width:medium; height:30px; text-align:left; vertical-align:middle; width:152px" %)Chronical Diseases: e.g., Persons With Chronic Pulmonary (Copd)|(% style="border-color:currentcolor; border-style:none; border-width:medium; text-align:justify; vertical-align:middle; width:152px" %)Cardiological Or Other Conditions (Aphasia)|(% style="border-color:currentcolor; border-style:none; border-width:medium; text-align:justify; vertical-align:middle; width:152px" %)Breast Cancer Survivors|(% style="border-color:currentcolor; border-style:none; border-width:medium; text-align:justify; vertical-align:middle; width:152px" %)(((
278 278  (% class="western" lang="en-GB" %)
279 -(% lang="en-US" %)Disabled people
280 -)))|(% style="border-color:currentcolor; border-style:none; border-width:medium; text-align:left; vertical-align:middle; width:153px" %)(((
281 -(% class="western" lang="en-GB" %)
282 -(% lang="en-US" %)Victims of trafficking in human beings
283 -)))|(% style="border-color:currentcolor; border-style:none; border-width:medium; text-align:left; vertical-align:middle; width:153px" %)(((
284 -(% class="western" lang="en-GB" %)
285 -(% lang="en-US" %)Ethnic minorities and immigrants
286 -)))|(% style="border-color:currentcolor; border-style:none; border-width:medium; text-align:left; vertical-align:middle; width:152px" %)(((
287 -(% class="western" lang="en-GB" %)
288 -(% lang="en-US" %)Isolated people
160 +
289 289  )))
290 -|(% style="border-color:currentcolor; border-style:none; border-width:medium; height:30px; text-align:justify; vertical-align:middle; width:153px" %)(((
291 -(% class="western" lang="en-GB" %)
292 -(% lang="en-US" %)Elderly people
293 -)))|(% style="border-color:currentcolor; border-style:none; border-width:medium; text-align:left; vertical-align:middle; width:153px" %)(((
294 -(% class="western" lang="en-GB" %)
295 -(% lang="en-US" %)Persons with serious illnesses
296 -)))|(% style="border-color:currentcolor; border-style:none; border-width:medium; text-align:left; vertical-align:middle; width:153px" %)(((
297 -(% class="western" lang="en-GB" %)
298 -(% lang="en-US" %)Homeless people
299 -)))|(% style="border-color:currentcolor; border-style:none; border-width:medium; text-align:left; vertical-align:middle; width:152px" %)(((
300 -(% class="western" lang="en-GB" %)
301 -(% lang="en-US" %)Ex-prisoners and people with criminal background
302 -)))
303 -|(% style="border-color:currentcolor; border-style:none; border-width:medium; height:12px; text-align:left; vertical-align:middle; width:153px" %)(((
304 -(% class="western" lang="en-GB" %)
305 -(% lang="en-US" %)Pregnant women
306 -)))|(% style="border-color:currentcolor; border-style:none; border-width:medium; text-align:left; vertical-align:middle; width:153px" %)(((
307 -(% class="western" lang="en-GB" %)
308 -(% lang="en-US" %)Persons with mental disorders
309 -)))|(% style="border-color:currentcolor; border-style:none; border-width:medium; text-align:left; vertical-align:middle; width:153px" %)(((
310 -(% class="western" lang="en-GB" %)
162 +
163 +:
164 +:
165 +: (% lang="en-US" %)Typical approaches to define (%%)//**professional **//end users in health and wellbeing living lab projects are presented in the following table .
166 +
167 +(((
168 +(% style="margin-left:auto; margin-right:auto; width:1694px" %)
169 +|(% colspan="4" style="border-color:#000000 currentcolor; border-style:solid none; border-width:1px medium; height:30px; text-align:center; vertical-align:middle; width:634px" %)**Informal Caregivers**
170 +|(% style="height:50px; text-align:justify; vertical-align:middle; width:152px" %)Part of adults and citizens' group|(% style="height:50px; text-align:justify; vertical-align:middle; width:152px" %) |(% style="height:50px; text-align:justify; vertical-align:middle; width:152px" %) |(% style="height:50px; text-align:justify; vertical-align:middle; width:152px" %)
171 +|(% colspan="4" style="border-color:#000000 currentcolor; border-style:solid none; border-width:1px medium; height:30px; text-align:center; vertical-align:middle; width:634px" %)**Health Care Professionals / Formal Caregivers**
172 +|(% style="height:30px; text-align:justify; vertical-align:middle; width:152px" %)Doctors|(% style="height:30px; text-align:justify; vertical-align:middle; width:152px" %)Social workers|(% style="height:30px; text-align:justify; vertical-align:middle; width:152px" %)Physiotherapists|(% style="height:30px; text-align:justify; vertical-align:middle; width:152px" %)Psychologists
173 +|(% style="border-color:currentcolor; border-style:none; border-width:medium; height:50px; text-align:justify; vertical-align:middle; width:152px" %)Registered nurses|(% style="border-color:currentcolor; border-style:none; border-width:medium; height:50px; text-align:justify; vertical-align:middle; width:152px" %)Practical nurses|(% style="border-color:currentcolor; border-style:none; border-width:medium; height:50px; text-align:justify; vertical-align:middle; width:152px" %)Physicians|(% style="border-color:currentcolor; border-style:none; border-width:medium; height:50px; text-align:justify; vertical-align:middle; width:152px" %)
174 +|(% colspan="4" style="border-color:#000000 currentcolor; border-style:solid none; border-width:1px medium; height:30px; text-align:center; vertical-align:middle; width:634px" %)**Students**
175 +|(% style="height:30px; text-align:justify; vertical-align:middle; width:152px" %)Medical|(% style="height:30px; text-align:justify; vertical-align:middle; width:152px" %)Engineering|(% style="height:30px; text-align:justify; vertical-align:middle; width:152px" %)Computer Science|(% style="height:30px; text-align:justify; vertical-align:middle; width:152px" %)Pedagogues
176 +|(% style="border-color:currentcolor; border-style:none; border-width:medium; text-align:justify; vertical-align:middle; width:152px" %)English Literature|(% style="border-color:currentcolor; border-style:none; border-width:medium; text-align:justify; vertical-align:middle; width:152px" %)Nursing|(% style="border-color:currentcolor; border-style:none; border-width:medium; text-align:justify; vertical-align:middle; width:152px" %)Physiotherapy|(% style="border-color:currentcolor; border-style:none; border-width:medium; text-align:justify; vertical-align:middle; width:152px" %)Social Services
177 +|(% style="border-color:currentcolor; border-style:none; border-width:medium; height:50px; text-align:justify; vertical-align:middle; width:152px" %)Health Care Management|(% style="border-color:currentcolor; border-style:none; border-width:medium; height:50px; text-align:justify; vertical-align:middle; width:152px" %) |(% style="border-color:currentcolor; border-style:none; border-width:medium; height:50px; text-align:justify; vertical-align:middle; width:152px" %) |(% style="border-color:currentcolor; border-style:none; border-width:medium; height:50px; text-align:justify; vertical-align:middle; width:152px" %)
178 +|(% colspan="4" style="border-color:#000000 currentcolor; border-style:solid none; border-width:1px medium; height:30px; text-align:center; vertical-align:middle; width:634px" %)**Organizations**
179 +|(% style="height:30px; text-align:justify; vertical-align:middle; width:152px" %)Hospitals|(% style="height:30px; text-align:justify; vertical-align:middle; width:152px" %)Nursing homes|(% style="height:30px; text-align:justify; vertical-align:middle; width:152px" %)Care homes|(% style="height:30px; text-align:justify; vertical-align:middle; width:152px" %)Home care Organizations
180 +|(% style="border-color:currentcolor; border-style:none; border-width:medium; text-align:justify; vertical-align:middle; width:152px" %)Network organizations|(% style="border-color:currentcolor; border-style:none; border-width:medium; text-align:justify; vertical-align:middle; width:152px" %)Day care centers|(% style="border-color:currentcolor; border-style:none; border-width:medium; text-align:justify; vertical-align:middle; width:152px" %) |(% style="border-color:currentcolor; border-style:none; border-width:medium; text-align:justify; vertical-align:middle; width:152px" %)
181 +
311 311  
312 -)))|(% style="border-color:currentcolor; border-style:none; border-width:medium; text-align:left; vertical-align:middle; width:152px" %)(((
313 -(% class="western" lang="en-GB" %)
314 -
315 315  )))
316 316  
317 317  :
318 318  
319 319  (% class="western" lang="en-GB" %)
320 -(% lang="en-US" style="page-break-before:always" %)Living lab research infrastructure end users and B2B-customers (% style="page-break-before:always" %)in health and wellbeing living lab projects are presented in Table .
188 +(% lang="en-US" style="page-break-before:always" %)Living lab research infrastructure end users and B2B-customers (% style="page-break-before:always" %)in health and wellbeing living lab projects are presented in (%%)the table below(% style="page-break-before:always" %) .
321 321  
322 322  |**Researcher expertise**|**Brief use case description**
323 -|Policy Makers|Studying the impact of new service models or new collaboration models in healthcare, designing or improving policies, gathering requirements for improving health and wellbeing of citizens, co-creation of research methodologies for policy making
324 -|Experts in communication studies|Defining written, oral, visual and digital communication within a certain workplace. Evaluating (multi professional) healthcare team collaboration, communication and debriefing in various healthcare situations in simulated environments (especially in Simulation lab)
325 -|Computer/Technology Scientists|Developing systems/tools/ technologies, testing and evaluating an ICT tool, prototype and real-life testing, computer vision & AI, Virtual Reality & Augmented Reality, Cybersecurity
326 -|(Clinical, social, developmental, neuro-) Psychologists|Studying the behaviour and the mental wellbeing of participants, conducting psychometrics evaluation and real-life setting experimentation/observation/real life testing
327 -|Social workers/researchers|Conducting an investigation in accordance with the scientific methods and tools, studying the impact of new care models and/or care innovations on society, developing models for a caring and inclusive society
328 -|Researchers with clinical expertise|(Doctors, nurses, healthcare workers, specialists, physiotherapists etc.), conducting research of healthcare services and practices, research on symptomatology or epidemiology of a disease, analysis of clinical effects of research performed in the study, e.g; via real life testing
329 -|Experts in UX research and assessment|Developing the process for user experience design (UXD, UED, or XD) supporting user behavior through usability, usefulness, and desirability provided in the interaction with a product or service, addressing all aspects as perceived by users with a focus on the quality of the user experience. Studying and experimenting the best practices for UI/UX and evaluating user’s experience in different situations and while using different tools
330 -|Experts in sport science|Experimenting novel training methods, and their effectiveness in various dimensions such as safety, engagement, and physical capabilities. Studying the impact of physical movements in various functions and wellbeing features
331 -|Experts in rehabilitation (physical, cognitive)|Physiology, physiotherapy, occupational health research, rehabilitation and prevention. Cognitive diseases assistive technology, neuromuscular rehabilitation assistive technology
332 -|Experts in performing arts|Creative health improvement (e.g. for cognitive decline) through music and dance (example: redesigning public spaces into healthy spaces: test and validate Smart methodologies, products and services through folk dance)
333 -|Business developers|Studying the product-market fit, matching a solution with a societal need, learning about the user acceptance of products and services, as well as about potential products to develop, willingness to pay, business model and ideal route to market
334 -|Pedagogues/educators|Evaluating different pedagogical approaches and their impact learning performance (especially in Simulation lab)
335 -|Experts in applied economics|Evaluating cost and performance in different healthcare processes, situations and public health
336 -|Experts in ergonomics and safety|Implementation and validation of ergonomic technologies/services to support workers and system performance, promoting ergonomics in working environments, improving both health/well-being and productivity, while avoiding occupational hazards
337 -|Citizen Scientists / users as co-researchers|User empowerment, training, design, analysis and implementation of strategies and methodologies for user engagement and for raising awareness and generating citizen participation
338 -|Biomedical researchers|Studying biochemical and physiological functions, investigating how the human body works with the aim of finding new ways to improve health. Biomedical engineering knowledge (Home hospitalization, Transitional Care, Multifunctional interaction), as well as digital biomarkers analysis (e.g. for cognitive state)
339 -|Experts in accessibility Design|Validating accessible Architectonics and escape route models with VR experiment and real-life simulations
340 -|Neuroscientists|Focusing on the brain and its impact on behaviour and cognitive functions (cognitive neuroscience, EEG-based BMI research, protocol / paradigm testing, study framework evaluation)
341 -|Innovation and design management researchers|Ecosystem and innovation management research, social network analysis. Evaluating how health and wellbeing ecosystem operates between different actors at local, regional, national and international level, including also scaling and commercialization
342 -|Experts in organizational studies|Co-creation, experimentation, organizational research, experts by experience / pier support included. Evaluation how multistakeholder collaboration and co-creation is done and how effective it is. Evaluates experimentations and experimentation culture. How users are involved into these processes
343 -|Data Scientists|Collecting, analysing and interpreting digital data, such as data analytics in healthcare and digital patient recordings (how patient information recording process is managed and utilized during the intervention by using digital tools in simulated situations)
191 +|(% style="vertical-align:middle" %)Citizen scientists, users as co-researchers|(% style="vertical-align:middle" %)User empowerment, training, design, analysis and implementation of strategies and methodologies for user engagement and for raising awareness and generating citizen participation.
192 +|(% style="vertical-align:middle" %)Computer, technology scientists|(% style="vertical-align:middle" %)Developing systems/tools/ technologies, testing and evaluating an ICT tool, prototype and real-life testing, computer vision & AI, Virtual Reality & Augmented Reality, Cybersecurity.
193 +|(% style="vertical-align:middle" %)Data scientists|(% style="vertical-align:middle" %)Collecting, analysing and interpreting digital data, such as data analytics in healthcare and digital patient recordings (how patient information recording process is managed and utilized during the intervention by using digital tools in simulated situations).
194 +|(% style="vertical-align:middle" %)Rehabilitation (physical, cognitive) experts|(% style="vertical-align:middle" %)Physiology, physiotherapy, occupational health research, rehabilitation and prevention. Cognitive diseases assistive technology, neuromuscular rehabilitation assistive technology.
195 +|(% style="vertical-align:middle" %)UX research and assessment experts|(% style="vertical-align:middle" %)Developing the process for user experience design (UXD, UED, or XD) supporting user behaviour through usability, usefulness, and desirability provided in the interaction with a product or service, addressing all aspects as perceived by users with a focus on the quality of the user experience. Studying and experimenting the best practices for UI/UX and evaluating user’s experience in different situations and while using different tools.
196 +|(% style="vertical-align:middle" %)Clinical expertise researchers|(% style="vertical-align:middle" %)(Doctors, nurses, healthcare workers, specialists, physiotherapists etc.), conducting research of healthcare services and practices, research on symptomatology or epidemiology of a disease, analysis of clinical effects of research performed in the study, e.g., via real life testing.
197 +|(% style="vertical-align:middle" %)Policymakers|(% style="vertical-align:middle" %)Studying the impact of new service models or new collaboration models in healthcare, designing or improving policies, gathering requirements for improving health and wellbeing of citizens, co-creation of research methodologies for policy making.
198 +|(% style="vertical-align:middle" %)Biomedical researchers|(% style="vertical-align:middle" %)Studying biochemical and physiological functions, investigating how the human body works with the aim of finding new ways to improve health. Biomedical engineering knowledge (Home hospitalization, Transitional Care, Multifunctional interaction), as well as digital biomarkers analysis (e.g., for cognitive state).
199 +|(% style="vertical-align:middle" %)Business developers|(% style="vertical-align:middle" %)Studying the product-market fit, matching a solution with a societal need, learning about the user acceptance of products and services, as well as about potential products to develop, willingness to pay, business model and ideal route to market.
200 +|(% style="vertical-align:middle" %)Innovation and design management researchers|(% style="vertical-align:middle" %)Ecosystem and innovation management research, social network analysis. Evaluating how health and wellbeing ecosystem operates between different actors at local, regional, national and international level, including also scaling and commercialization.
201 +|(% style="vertical-align:middle" %)Accessibility design experts|(% style="vertical-align:middle" %)Validating accessible architectonics and escape route models with VR experiment and real-life simulations.
202 +|(% style="vertical-align:middle" %)Ergonomics and safety experts|(% style="vertical-align:middle" %)Implementation and validation of ergonomic technologies/services to support workers and system performance, promoting ergonomics in working environments, improving both health/well-being and productivity, while avoiding occupational hazards.
203 +|(% style="vertical-align:middle" %)Organizational studies experts|(% style="vertical-align:middle" %)Co-creation, experimentation, organizational research, experts by experience / pier support included. Evaluation how multistakeholder collaboration and co-creation is done and how effective it is. Evaluates experimentations and experimentation culture. How users are involved into these processes.
204 +|(% style="vertical-align:middle" %)Neuroscientists|(% style="vertical-align:middle" %)Focusing on the brain and its impact on behaviour and cognitive functions (cognitive neuroscience, EEG-based BMI research, protocol / paradigm testing, study framework evaluation).
205 +|(% style="vertical-align:middle" %)Psychologists (clinical, social, developmental, neuro)|(% style="vertical-align:middle" %)Studying the behaviour and the mental wellbeing of participants, conducting psychometrics evaluation and real-life setting experimentation/observation/real life testing.
206 +|(% style="vertical-align:middle" %)Social workers/researchers|(% style="vertical-align:middle" %)Conducting an investigation in accordance with the scientific methods and tools, studying the impact of new care models and/or care innovations on society, developing models for a caring and inclusive society.
207 +|(% style="vertical-align:middle" %)Sport science experts|(% style="vertical-align:middle" %)Experimenting novel training methods, and their effectiveness in various dimensions such as safety, engagement, and physical capabilities. Studying the impact of physical movements in various functions and wellbeing features.
208 +|(% style="vertical-align:middle" %)Communication studies experts|(% style="vertical-align:middle" %)Defining written, oral, visual and digital communication within a certain workplace. Evaluating (multi professional) healthcare team collaboration, communication and debriefing in various healthcare situations in simulated environments (especially in Simulation lab).
209 +|(% style="vertical-align:middle" %)Performing arts experts|(% style="vertical-align:middle" %)Creative health improvement (e.g., for cognitive decline) through music and dance (example: redesigning public spaces into healthy spaces: test and validate Smart methodologies, products and services through folk dance).
210 +|(% style="vertical-align:middle" %)Pedagogues/educators|(% style="vertical-align:middle" %)Evaluating different pedagogical approaches and their impact learning performance (especially in Simulation lab).
211 +|(% style="vertical-align:middle" %)Applied economics experts|(% style="vertical-align:middle" %)Evaluating cost and performance in different healthcare processes, situations and public health.

This project has received funding from the European Union’s Horizon 2020 research and innovation programme under grant agreement No 101007990

Copyright © 2021 VITALISE Project